Furxiga Trademark Details
Word Mark | Furxiga |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Serial Number | 86049280 |
---|---|
Status Date | Monday, October 20, 2014 |
Filing Date | Monday, October 20, 2014 |
Attorney | Marc Stanislawczyk |
Correspondent
Marc Stanislawczyk
AstraZeneca Pharmaceuticals LLP
FOP3-022
1800 Concord Pike
Wilmington DE 19850-5437
AstraZeneca Pharmaceuticals LLP
FOP3-022
1800 Concord Pike
Wilmington DE 19850-5437
Case File Statements
Goods & Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Thursday, September 5, 2013 |
Primary Code | 005 |
Trademark Timeline
-
Aug 27 2013Trademark application filed with USPTO
-
Aug 30 2013New Application Entered In Tram
-
Sep 05 2013New Application Office Supplied Data Entered In Tram
-
Dec 10 2013Assigned To Examiner
-
Dec 16 2013Approved For Pub - Principal Register
-
Jan 01 2014Notification of Notice of Publication E-Mailed
-
Jan 21 2014Official Gazette Publication Confirmation E-Mailed
-
Jan 21 2014Published For Opposition
-
Mar 18 2014Attorney Revoked And/or Appointed
-
Mar 18 2014Teas Revoke/appoint Attorney Received
-
Mar 18 2014Noa E-Mailed - Sou Required From Applicant
-
Mar 19 2014Automatic Update of Assignment of Ownership
-
Oct 08 2014Assignment of Ownership Not Updated Automatically
-
Oct 20 2014Abandonment Notice Mailed - No Use Statement Filed
-
Oct 20 2014Abandonment - No Use Statement Filed